ICH guidelines
ICH guidelines are globally harmonized scientific rules for validating analytical laboratory tests. They set a common standard for how laboratories confirm that tests for identity, purity, and safety are accurate, reliable, and reproducible.
Also called: International Council for Harmonisation guidelines, ICH
ICH guidelines are globally harmonized scientific and technical standards for pharmaceutical registration. These rules are developed by the International Council for Harmonisation (ICH), a collaborative initiative between major regulatory authorities - including the US FDA, European EMA, and Japan's PMDA - and pharmaceutical industry experts to ensure international consistency.
ICH guidelines standardize method validation in laboratory testing
ICH guidelines standardize how laboratories validate analytical methods rather than testing substances directly. For example, ICH Q2 requires labs to prove method accuracy and precision, ICH Q6A provides the framework for acceptance criteria, and ICH Q3B sets thresholds for impurities. These standards ensure that laboratory testing follows globally recognized scientific procedures.
On a Certificate of Analysis (CoA), a claim that a method is "validated according to ICH guidelines" indicates that the laboratory followed these pharmaceutical-grade standards. Although ICH guidelines were designed for drugs seeking formal marketing authorization, vendors often apply them voluntarily to "research use only" (RUO) peptides to provide a standardized level of quality assurance.
Common confusions about ICH guidelines
- ICH is not a specific test method, such as HPLC.
- ICH is not a regulator; it writes the guidelines that authorities like the FDA adopt.
- ICH is not GMP (Good Manufacturing Practice), which is a manufacturing quality system.
- ICH is not a pharmacopeia, which publishes legally binding test methods for specific substances.
Sources
- ICH Q2(R2) Guideline on validation of analytical procedures_Step 5
- Regulatory Guidelines for the Analysis of Therapeutic Peptides and ...
- Q6A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances | FDA
- test procedures and acceptance criteria for new drug substances ...
- Q3B(R) Impurities in New Drug Products (Revision 3) | FDA
- [PDF] Guideline on the Development and Manufacture of Synthetic Peptides
- [PDF] ICH guideline Q10 on pharmaceutical quality system - Step 5 - EMA
- ICH guidelines: Quality | European Medicines Agency (EMA)
- Q 7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
- GMP, ISO, FDA and BIS: Regulatory Compliance in India
- Comparison of ICH Q2(R2) vs FDA Expectations for Analytical Method Validation – Pharma Validations
- GMP vs ISO vs ICH vs FDA: Quality Frameworks Compared
- [PDF] 1-6 Specifications
- ICH Q2(R2) Validation of analytical procedures - Scientific guideline | European Medicines Agency (EMA)
- International Council on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) | European Medicines Agency (EMA)
- ICH Q4B and FDA Expectations: How to Justify Pharmacopeial Equivalence – PharmaRegulatory.in – India’s Regulatory Knowledge Hub
- Q2(R1) Validation of Analytical Procedures: Text and Methodology Guidance for Industry | FDA